Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Scholars
GetInsulin.org
Community Table
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
Research
Vertex VX-880 Clinical Results Lead To Insulin-Independence
Here's what you need to know about Vertex's recent results from their stem-cell therapy for type 1 diabetes.
Why Diabetes Should be Screened by Age Instead of Weight
Many cases of diabetes may be missed by screening only by weight instead of age, especially for some racial and ethnic groups.
Participate in Type 1 Diabetes Research From Home
Here are two simple ways to get involved in type 1 diabetes research that strives to improve the care provided to people with T1D.
Dedicated to Helping People With T1D: Dr. Gary Meininger on His Life and Career with Diabetes
We spoke with Dr. Meininger on his personal connection to T1D, his role at Vertex, and important work being done in clinical trials.
Are People with Type 1 Diabetes Immunocompromised?
People with type 1 diabetes have been getting mixed messages throughout COVID-19. Here, we clarify - does T1D mean immunocompromised or not?
The PROTECT Study
The PROTECT Study aims to understand how the investigational medicine, teplizumab, works in children and young adults who have recently been diagnosed with T1D, as well as assessing if there are any s...
Talking T1Detect, the New T1D Testing Program from JDRF
On the newest episode of Diabetes Connections, host Stacey Simms talks to the Director of Research at JDRF, Frank Martin, about the new T1Detect program.
JDRF Launches Program to Advance Universal Screening for Type 1 Diabetes
T1Detect is a new screening initiative designed to make early detection of type 1 diabetes easier and more accessible to a broad population.
From Diagnosis Through Complications: Disparities in Diabetes Care
Recent research is confirming what many have experienced - that beginning at diagnosis, ethnic minorities in the US face more challenges navigating diabetes and care than their white counterparts.
vTv Therapeutics Announces Positive Study Results of Potential First-in-Class Oral Adjunctive Therapy for T1D
On February 10, vTv Therapeutics announced positive study results from the second part of the Phase 2 Simplici-T1 Study of TTP399.
New Evidence Shows Vital Importance of Screening For T1D in Children
By screening for type 1 diabetes in children, Bavaria was able to decrease rates of diabetic ketoacidosis at diagnosis.
Implanted PEC-01 Cells Capable of Producing Insulin According to New Data Presented from ViaCyte
ViaCyte presented preliminary data from their PEC-Direct trial, showing that PEC-01 cells are capable of producing insulin in patients with type 1 diabetes.
Clinical Trials and the Type 1 Diabetes Cure
Genetic risk and environmental factors are part of the cure for type 1 diabetes conversation. Learn about clinical trials and risk factors.
The Human Trial and What it Means for a Cure
Viacyte is conducting the first-ever clinical trial to implant stem-cell-derived beta cells into humans, called The Human Trial. Learn more.